Altered liver expression of IGFBP1 and G6P has been reported in patients with NASH [20,21] and metallothioneins may play preventive roles against obesity through reduction of oxidative stress. The gene discussed is IGFBP1; the disease is obesity due to melanocortin 4 receptor deficiency.